Member Info for ART123

There's very little point in selling at a loss. This share has gone from 1p to 3p many times over the last 2/3 years and there is no reason it won't do that again. And the testing is all going very well anyway. Just give it time. It's still poor management though by SS to let it happen though.

Quick question. Is the £1 million generated so far for the whole of the Horse Hill consortium or is that net to UKOG?

Any sensible CEO would get a placing out when the shareprice is at a highish level. Also he keeps buying more assets and paying with shares which just leads to the vendors selling off the shares which just crashes the shareprice unnecessarily. Very silly.

I can't believe that there's going to be a chance to buy/top-up at 1p here soon. That wasn't expected especially as the testing has all gone pretty well so far. I know we are still waiting for the KL-4 flow rates but they should be more or less a formality at least at a similar flow rate to the previous test in 2016.

I quite agree Sanderson doesn't have a clue how to manage an AIM share. He is hopeless. He always waits and waits to do a placing until the shareprice is at rock bottom which causes huge dilution. Any sensible CEO would

I was expecting a sell on news scenario here even though it was difficult to see how the company could release news that would say they had started the flow test yet somehow still have a negative slant. Now it is all obvious.

Sell on news. Works well here because news is so infrequent and most of the value is built due to shareholders piecing together sketchy rumours and goings on.

It's not the market that is dead here it is the management. They are sat around in the Philippines running the company at Philippines speed which is far too slow for the UK and the London Stock Market. The management have set a stupidly slow speed for growth that is reflected in the shareprice and the total lack of interest in this share from shareholders and posters. For days on end there are no posts here at all. And the only thing that is propping up the shareprice from further falls is that for day after day there are no trades at all either. Otherwise the SP would probably be around 1p by now.

They hit their first target of an extra 60/70 restaurants weeks ago and now want to begin the rollout to 6000 participating outlets in the UK. They appear to have targeted London rather than Bristol and Bath which is a good positive move as there are many times more restaurants in London than these other cities and this seems to have been achieved easily so now they need to begin the next stage.

Most of the restaurants in the UK are still live on the Table Pouncer website though they do have about 8 in Bath on the BigDish app but how long are they going to take to get past any bugs, etc. remains to be seen. In truth they have already taken far too long. The Table Pouncer website also has an annoying way of insisting that you register before viewing any deals which is a dreadfully off-putting and out-of-date way to operate. At least the Big Dish app lets you just browse. Also the Big Dish app clearly sets out the times and the amount of discount so diners are still able to use the app at peak times but with less discount which is good. The company clearly needs to work out which website/app to use or even to keep using both.

In retrospect a target of 250 or 500 participating restaurants live by Xmas would have been a quite doable and more sensible target and would have been reflected in a higher shareprice and far more interest here.

Another poor or missed target RNS will definitely see the shareprice down to 1p and will be very frustrating so the management need to buck up and get the fact that they are now a public listed company with a responsibility to shareholders.

Don't get me wrong I think this is a brilliant prospect and could be one of the best shares of 2019 in terms of pure growth but only if the management get a bloody move on. They have first mover advantage and need to get these restaurants signed up as quickly as possible. There is no time here for delays or hanging around waiting for January. Action needs to start today.

ATB

It's just a shame that the management here have such a problem with communication. They take it for granted that everyone knows what is going on but we really don't and it's all left to individuals seeking here and there and piecing all the snippets of info together to try and work out what is going on and when.

Shame really and another example of poor management and management taking their salaries for granted. This is a public listed company with shareholders and these shareholders should be kept informed by RNS about operations.

It doesn't really matter what the shareprice does for the next few months. They now have the funds needed to continue operations which are due to restart in Q2 2019 which is all that counts. The shareprice recovered earlier this year and it is most likely to do the same next year. My only interest if the shareprice drops in the meantime will be to pick up some more to bring my average down.

Well I bought in at 9p after the previous failed placing was announced. It was unfortunate but seemed like a genuine placing unfortunately followed by a negative update which the management wouldn't have known about at the time.

I've waited and now bought an equal amount today so my average is now under 6p and I will get some more between now and when operations restart to try and get that down to below 5p or even below 4p.

There's nothing I can do about it but sit and wait but I have noticed that the shareprice here was as low as 2p this time last year and only started to pick up when operations started. When it did rise it went as high as 10p/12p and that was with roughly 60 million shares. There are now 90 million which with the dilution would see the 10p/12p as about 8p.

They now have the funds to get the testing done. They've said repayment of the loan can be deferred if necessary. They previously had cash to see them through to the end of Q1 and now this placing should see them through another 2 quarters.

And of course none of this takes into account the upside if the operations are successful. I expect some of the long termers here will have forecasts done for a successful outcome which I assume will be many multiples of the current £2 Million m/cap (which peaked at about £7 Million earlier this year).

ATB

For example that 100,000 trade at 13.38.29 was clearly a buy at the time. The MM's have had a real field day here and have managed to turn what has to have been a strong buying day into figures that say just over 3 million buys and 7.4 million sells. Crazy. It's probably more likely the other way round.

32p being paid now.

Most of the late reported big trades coming through from an hour or two ago are probably buys. I bought in earlier at 34.5p so was a bit worried when the SP fell but I think it will be back to around that price by close or at least in the morning.

Of course the question now is whether this is going to re-rate over the next few days to a more sensible and realistic level for this encouraging news.

Yearly high is over 70p.

Collaboration agreement with LG

Headlines

The Affimer therapeutics development collaboration with the multi-national, multibillion-dollar group, LG, represents a major endorsement of AVCT’s Affirmer technology platform. LG is a strong partner, and its wholly-owned pharmaceutical subsidiary, LG Chem, has a track record of being able to develop new biopharmaceutical drugs all the way to commercialisation. The first part of this deal would entitle AVCT to receive up to $180m in upfront payments and milestones, which falls within the normal range for access to such assets and is particularly good
for a platform that is yet to be validated in man, event expected to happen in 2020.
In return, LG receives the exclusive rights to develop and commercialise, on a
worldwide basis, multiple Affimer molecules in two therapeutic areas:

? inflammatory disorders; and

? oncology

Under the terms of the agreement, the collaboration is segregated into three stages:

? Step 1: AVCT to generate Affimers and carry out the discovery, optimisation
and protein engineering of Affimer drug candidates against a number of
undisclosed targets.

? Step 2: LG and AVCT to collaborate to progress these candidates through to
drug candidate selection.

? Step 3: LG to be responsible for the pre-clinical and clinical development, and
worldwide marketing of any resulting products.

Moreover, LG has the option to add further targets and, if the option is exercised, AVCT will be entitled to receive up to an additional $130m in fees and milestone payments. This values the whole agreement at $310m.

LG Chem Life Sciences is a business division within LG Chem, itself part of the LG Group. LG Chem was founded in 1947 and is now the leading chemical industry in Korea, with more than 29,000 employees and annual sales totalling KRW25.7 trillion ($23bn/£18bn). It is engaged in the development, manufacturing and commercialisation of pharmaceutical products globally.

It seems to be increasingly obvious that the management are not wise to the ways of the Stock Market. Shareholders crave news. They also need fast progress and for the business to grow quickly. Anything else and the sharepice will just go down, down, down.

I first came across this business idea when Nyota were going to do a reverse takeover and that was around November 2016. I know that for a fact as I've just checked the Nyota RNS's which are still on Investegate. That means the management here have already taken 2 years just to get this floated and up and running with a tiny handful of restaurants on board. They need to get a bloody move on. This is stupidly slow. I repeat they have first mover advantage in the UK and the growth opportunity is fantastic - at least unless they just sit around doing nothing until the cash runs out. This type of business with very low overheads should quickly run on the income which if they grow quickly will far outstrip the expenses.

Everyone else on this board has got bored and gone elsewhere. The market is a fast moving machine. I'm still here with one or two others trying to keep the lights on but it's getting harder and harder.

ATB

Sorry if this sounds a bit harsh but there is nothing going on here at all. Not that there is anyone left here anyway. Everyone got bored waiting for this lot to get this business up and running a long time ago. The shareprice is falling fast while the management do nothing except take on a joint broker and we all know where that usually leads.

This could be phenomenal or as it is at the moment just plain boring. We could all make fantastic returns or the sharepice could just get diluted to nothing.

All just my opinion.

I'm afraid the shareprice reflects the fact that the management have set really slow targets for getting this business started up and the market quite simply expects more. They already have the 60/70 restaurants on board so now is the time to start rolling this out across the country. What are they waiting for. The market obviously thinks they have stopped functioning and are sitting around doing nothing as the shareprice is less than half the IPO price and still falling. The market is a harsh place. If it gets noticed that nothing is happening or that they are falling behind on the targets then that gets reflected in the shareprice.

They have first mover advantage here and need to get established as the name for this type of discount operation. The potential is huge but only if they get a move on. The sooner they start signing restaurants to their website/APP the sooner they will have revenue coming in to fund the expansion. If they sit around doing nothing then they'll soon run out of cash and need to do a placing just to fund their lazy lifestyle.

ASOS was a stockmarket phenomenon with the shareprice going from 12p to £70 but during this whole growth period the company didn't do one single placing. There were the same number of shares in issue when the shareprice hit the highs as at the very beginning. And that was despite their business needing warehouse facilities, packing and postage not to mention the dreadful returns. This business is very simple compared to that. Big Dish don't need to own any restaurants or have vast numbers of staff picking and packing orders. All they need is a small office - 15 staff - with half of those based in the Philippines.

They already have around 100 outlets live every day - or weekdays at least - so what they are doing obviously works and they are getting very good local reviews but now that figure needs to be 200,300, 500 and 1000 outlets as quickly as possible. Why wait around.

Just Eat have already established a hugely successful take away website/APP and they don't have anywhere near the attractive deals that Big Dish can offer. They have a m/cap of just under £4 Billion (which has been as high as £6 Billion) with 97,000 outlets on board, about half of which are in the UK. On a direct comparison when Big Dish get to 6000 participation restaurants that could give a m/cap of between £250 and £350 Million - potentially over £1 per share which would be phenomenal growth in one year.

Or are the management going to sit back and take too long, to stop off and think about selling the Asian business which they should instead be expanding too, and run out of cash and have to dilute the f*ck out of the shareprice. Personally I'd prefer them to get a move on.

Oh dear, not much confidence in this at the moment.

Shareprice is back to where it was before the discovery of the 300 - 500 Bcf''s - or was in 32 Tcf''s they discovered - I can't seem to remember now.

Interesting read out today:

https://thelatest.co.uk/tablepouncer/

Done it again. To continue;

By the way I am not an investor/LTH by a long way. I am an out and out trader. I like to hold shares for anything from an hour to a day and if I'm still holding any a week after buying them then I guarantee they will be at a large paper-loss. However I am quite happy to hold these because there is so much potential here.

Sorry this got posted before I'd finished. To continue:

The plan was to have 60 to 70 new restaurants signed up by the end of 2018 in Bristol and Bath. Today, looking at the Table Pouncer website, there are 60 to 70 new outlets live but instead of being in Bristol and Bath they are in London, Southampton, Brighton and Bristol. This is in addition to the participating outlets in Bournemouth. Bath and Edinburgh are also listed as ready to start soon. To my mind London is a great place to start early with a huge, huge potential market - many, many times the size of say Bournemouth and an all year round market too.

As long as the management stick to the plan this has got huge potential.

By the way I am not an investor/LTH by a long way.